Sign Up Today and Learn More About Tsingke Biotech Stock
Invest in or calculate the value of your shares in Tsingke Biotech or other pre-IPO companies through EquityZen's platform.
Tsingke Biotech Stock (TSBI)
Tsingke Biotechnology specializes in the research and development of synthetic genomics and biosynthetic products.
About Tsingke Biotech Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Tsingke Biotech Press Mentions
Stay in the know about the latest news on Tsingke Biotech
Tsingke Concludes a Successful Showcase at TIDES USA 2024: Advancing Biotechnology Frontiers
prnewswire • Jun 25, 2024
ANGPTL4 binds to the leptin receptor to regulate ectopic bone ...
pnas • Jan 31, 2024
Fungal secondary metabolism is governed by an RNA-binding ...
nature • Jan 31, 2024
Feeding Spodoptera exigua larvae with gut-derived ...
nature • Jan 31, 2024
A fitness trade-off between growth and survival governed by ...
science • Jan 31, 2024
Join now and verify your accreditation status to gain access to:
- Tsingke Biotech current valuation
- Tsingke Biotech stock price
- Available deals in Tsingke Biotech and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Tsingke Biotech Stock
How to invest in Tsingke Biotech stock?
Accredited investors can buy pre-IPO stock in companies like Tsingke Biotech through EquityZen funds. These investments are made available by existing Tsingke Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tsingke Biotech stock?
Shareholders can sell their Tsingke Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
